Israel's Teva Looks To China For Possible JVs To Expand Presence
This article was originally published in PharmAsia News
Executive Summary
Israel-based Teva Pharmaceutical Industries, already active in Japan and South Korea, sees China as a new market for its focus, which could include a joint venture to gain a presence.